Regulation of TLR 7 / 9 responses in plasmacytoid dendritic cells by BST 2 and ILT 7 receptor interaction
暂无分享,去创建一个
L. Lanier | M. Cho | W. Cao | Yi-hong Wang | S. Hanabuchi | Chun Li | X. Wen | N. Arai | Musheng Bao | L. Bover | J. Shaw | D. Rosen | Z. Yao | Qiumei Du | Yong‐jun Liu
[1] L. Coscoy,et al. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress , 2009, The Journal of experimental medicine.
[2] A. Makrigiannis,et al. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC , 2008, The Journal of experimental medicine.
[3] J. Blay,et al. Breast tumor environment inhibits human plasmacytoid dendritic cell functions , 2008 .
[4] Lewis L Lanier,et al. Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.
[5] D. McVicar,et al. Paired Receptor Systems of the Innate Immune System , 2008, Current protocols in immunology.
[6] Marc C. Johnson,et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. , 2008, Cell host & microbe.
[7] E. Latz,et al. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. , 2008, Immunity.
[8] P. Bieniasz,et al. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu , 2008, Nature.
[9] R. Küppers,et al. CD303 (BDCA‐2) signals in plasmacytoid dendritic cells via a BCR‐like signalosome involving Syk, Slp65 and PLCγ2 , 2007, European journal of immunology.
[10] I. Mellman,et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.
[11] T. Ariga,et al. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. , 2007, International immunology.
[12] L. Lanier,et al. BDCA2/FcɛRIγ Complex Signals through a Novel BCR-Like Pathway in Human Plasmacytoid Dendritic Cells , 2007, PLoS biology.
[13] L. Audoly,et al. Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.
[14] A. Marshak‐Rothstein,et al. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. , 2007, Annual review of immunology.
[15] T. Junt,et al. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. , 2006, Blood.
[16] Robert D. Schreiber,et al. Interferons, immunity and cancer immunoediting , 2006, Nature Reviews Immunology.
[17] K. Honda,et al. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors , 2006, Nature Reviews Immunology.
[18] D. Kohda,et al. Crystal Structure of the Human Monocyte-activating Receptor, “Group 2” Leukocyte Ig-like Receptor A5 (LILRA5/LIR9/ILT11)* , 2006, Journal of Biological Chemistry.
[19] C. Figdor,et al. Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after FcγRII-mediated uptake , 2006, The Journal of experimental medicine.
[20] Wei Cao,et al. Plasmacytoid dendritic cell–specific receptor ILT7–FcɛRIγ inhibits Toll-like receptor–induced interferon production , 2006, The Journal of experimental medicine.
[21] D. Kohda,et al. Crystal structure of the human monocyte-activating receptor, , 2006 .
[22] E. Berti,et al. Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma. , 2006, Clinical immunology.
[23] S. Akira,et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. , 2006, Blood.
[24] J. Connolly,et al. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. , 2006, Blood.
[25] M. Colonna,et al. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. , 2006, Blood.
[26] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[27] S. Akira,et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8 , 2005, The Journal of experimental medicine.
[28] M. Colonna,et al. Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. , 2005, Blood.
[29] T. Bieber,et al. Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions. , 2005, American journal of clinical pathology.
[30] T. Curiel,et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. , 2005, Cancer research.
[31] L. Lanier,et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell–mediated innate resistance to cytomegalovirus infection , 2005, Nature Genetics.
[32] G. Trinchieri,et al. Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.
[33] J. Blay,et al. Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer , 2004, Clinical Cancer Research.
[34] J. Trowsdale,et al. The LILR family: modulators of innate and adaptive immune pathways in health and disease. , 2004, Tissue antigens.
[35] D. Olive,et al. Plasmacytoid DCs and cancer: a new role for an enigmatic cell. , 2004, Trends in immunology.
[36] T. Bieber,et al. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. , 2004, The Journal of allergy and clinical immunology.
[37] B. Teicher,et al. Identification of genes expressed in malignant cells that promote invasion. , 2003, Cancer research.
[38] L. Calabrese,et al. Induction of Clinical Autoimmune Disease by Therapeutic Interferon-α , 2003, Autoimmunity.
[39] George Banting,et al. Bst‐2/HM1.24 Is a Raft‐Associated Apical Membrane Protein with an Unusual Topology , 2003, Traffic.
[40] T. Giese,et al. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. , 2003, Cancer research.
[41] C. Sutherland,et al. ULBP4 is a novel ligand for human NKG2D. , 2003, Biochemical and biophysical research communications.
[42] L. Lanier,et al. NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.
[43] V. Cerundolo,et al. Plasmacytoid dendritic cells prime IFN‐γ‐secreting melanoma‐specific CD8 lymphocytes and are found in primary melanoma lesions , 2003, European journal of immunology.
[44] A. Diefenbach,et al. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity , 2003, European journal of immunology.
[45] D. Fremont,et al. Cutting Edge: Murine UL16-Binding Protein-Like Transcript 1: A Newly Described Transcript Encoding a High-Affinity Ligand for Murine NKG2D1 , 2002, The Journal of Immunology.
[46] D. Fremont,et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] L. Lanier,et al. Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.
[48] Antonio Lanzavecchia,et al. BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction , 2001, The Journal of experimental medicine.
[49] D. Olive,et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. , 2001, Blood.
[50] T. Curiel,et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells , 2001, Nature Medicine.
[51] Antonio Lanzavecchia,et al. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells , 2001, European journal of immunology.
[52] N. Kadowaki,et al. Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.
[53] A. Diefenbach,et al. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity , 2001, Nature.
[54] R. Armitage,et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.
[55] T. Mcclanahan,et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. , 2000, Immunity.
[56] P. Bjorkman,et al. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.
[57] A Steinle,et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.
[58] M. Tsuchiya,et al. Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. , 1999, Biochemical and biophysical research communications.
[59] M. Colonna,et al. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA‐G1 and HLA‐E molecules co‐expressed on target cells , 1999, European journal of immunology.
[60] M. Cooper,et al. Impairment of T and B Cell Development by Treatment with a Type I Interferon , 1998, The Journal of experimental medicine.
[61] M. Kubin,et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.
[62] W. Yokoyama,et al. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells , 1992, Nature.
[63] M. Clare-Salzler,et al. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases , 2009 .
[64] K. Arai,et al. SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production. , 2008, International immunology.
[65] R. Schreiber,et al. Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation , 2006 .
[66] Yong‐jun Liu,et al. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.
[67] V. Pascual,et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. , 2001, Science.